A phase 3 randomized study of cabozantinib (XL184) vs everolimus in subjects with clear cell renal cell carcinoma (METEOR) Meeting Abstract

  


Authors: Choueiri, T. K.; Escudier, B.; Powles, T.; Cella, D.; Lee, Y.; Laird, D. A.; Scheffold, C.; Motzer, R. J.
Abstract Title: A phase 3 randomized study of cabozantinib (XL184) vs everolimus in subjects with clear cell renal cell carcinoma (METEOR)
Meeting Title: 12th International Kidney Cancer Symposium
Journal Title: BJU International
Volume: 112
Issue: Suppl.3
Meeting Dates: 2013 Oct 25-26
Meeting Location: Chicago, IL
ISSN: 1464-4096
Publisher: Wiley Blackwell  
Date Published: 2013-11-01
Start Page: 4
Language: English
ACCESSION: WOS:000325992100008
PROVIDER: wos
Notes: Meeting Abstract: 7 -- 12th International Kidney Cancer Symposium -- OCT 25-26, 2013 -- Chicago, IL -- 3 -- SI -- Source: Wos